Almac Discovery publishes USP7 inhibitors from UbiPlexTM Platform
Craigavon, N.I., UK, 4 December 2017 – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, has today published its findings on the discovery and characterisation of highly potent, selective and reversible inhibitors of ubiquitin-specific protease 7 (USP7) in the journal Nature Chemical Biology. Despite substantial efforts over nearly two decades, the development of validated deubiquitinase (DUB) inhibitors that exhibit drug like properties and a well-defined mechanism has proven particularly challenging—overall, Almac’s findings successfully demonstrate the tractability and druggability of DUBs, and provide important tools for additional target validation studies.
Saint Joseph’s University Named a Military Times Best College for Veterans
PHILADELPHIA (November 21, 2017) – Saint Joseph’s University has been named one of Military Times Best Colleges for Veterans for 2018. Announced on Monday, Nov. 20, the distinction recognizes universities with a commitment to providing quality educational opportunities for veterans and military-connected students.
Local Spark Creates Momentum for International Success, SmartInvest Ventures Welcomes New Partner
WILMINGTON, Delaware, November 29, 2017 – SmartInvest Ventures (“SmartInvest”), an international venture capital firm, announced today that Martin Hunt, joins the team as a general partner, along side Charles “Chuck” Kerrigan, Fred Hosaisy and managing general partner, Gerry Moan. With more than 25 years of experience in private equity, insurance, strategy consulting and investment banking with over $20 billion in M&A transactional experience, along with degrees from the Harvard Business School and Swarthmore College – where he was a McCabe scholar, Mr. Hunt brings both his expertise and local connections to SmartInvest’s newest geographical focus – Delaware.
Independence Blue Cross Foundation partners with Penn State University to address the stigma of opioid addition
Philadelphia, PA — At an opioid crisis update event hosted at Independence Blue Cross (Independence) with Pennsylvania Governor Tom Wolf, Independence president and CEO Daniel J. Hilferty announced a new initiative to fight the stigma of addiction. The initiative pairs the Independence Blue Cross Foundation with the Justice Center for Research at Penn State University for a multi-media public awareness campaign to share stories of addiction and recovery to reduce the shame often associated with opioid abuse. The initiative will support the development and launch of a campaign to tell real stories of recovery, giving a face and voice to those affected by the crisis. The campaign will also explore the effect of substance abuse on individuals, families and the community.
We are thrilled to congratulate Eileen McDonnell, our 2017 Taoiseach Award honoree, on being recognized by Concern Worldwide at the Seeds of Hope Dinner in New York.